# Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-tv-46000-a-long-acting-subcutaneous-injectable/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John M. Kane,Eran Harary,Roy Eshet,Orna Tohami,Mark Weiser,Stefan Leucht,Avia Merenlender‐Wagner,Nir Sharon,Glen L Davis,Mark Suett,Kelli R. Franzenburg,Christoph U. Correll |
| Citations | 31 |
| DOI | 10.1016/s2215-0366(23)00288-2 |
| Fields | Medicine,Psychology |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4388227141 |
| PMID | 37924833 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Eran Harary](https://scholariq.org/researchers/eran-harary/)

## Paper journal

- [The Lancet Psychiatry](https://scholariq.org/journals/the-lancet-psychiatry/)

## Paper primary topic

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)

## Paper topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Healthcare Decision-Making and Restraints](https://scholariq.org/topics/healthcare-decision-making-and-restraints/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.